11th week of 2018 patent applcation highlights part 8 |
Patent application number | Title | Published |
20180071226 | Biocompatible Cross-Linked Micro-Nano Material Used for Drug Loading and Sustained Release and Construction Method Thereof | 2018-03-15 |
20180071227 | Sheet Packs And Methods For Manufacturing | 2018-03-15 |
20180071228 | Trans-Dermal Vitamin Assembly | 2018-03-15 |
20180071229 | COMPOSITIONS COMPRISING MIXTURES OF SEMIFLUORINATED ALKANES | 2018-03-15 |
20180071230 | FORMULATIONS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USES THEREOF | 2018-03-15 |
20180071231 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | 2018-03-15 |
20180071232 | COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY INJURY OR DISEASE | 2018-03-15 |
20180071233 | COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISEASES | 2018-03-15 |
20180071234 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL MISALIGNMENT | 2018-03-15 |
20180071235 | ANTIMICROBIALS AND METHODS OF USE THEREOF | 2018-03-15 |
20180071236 | LIQUID DOSAGE FORMS OF SODIUM NAPROXEN | 2018-03-15 |
20180071237 | TREATMENT METHOD FOR IMPROVING INTESTINAL ENVIORNMENT AND INTESTINAL TRACT BARRIER | 2018-03-15 |
20180071238 | Compositions and Methods for Traumatized Tissues Using Zinc Chelators | 2018-03-15 |
20180071239 | TYROSINASE ACTIVITY INHIBITOR AND EXTERNAL PREPARATION FOR SKIN | 2018-03-15 |
20180071240 | ONCE DAILY ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN | 2018-03-15 |
20180071241 | COMPOSITION INHIBITING GRAM-POSITIVE, PATHOGENIC BACTERIA | 2018-03-15 |
20180071242 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | 2018-03-15 |
20180071243 | USE OF FERRIC CITRATE IN THE TREATMENT OF IRON-DEFICIENCY ANEMIA | 2018-03-15 |
20180071244 | USE OF DIANHYDROGALACTITOL OR DERIVATIVES OR ANALOGS THEREOF FOR TREATMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM MALIGNANCIES | 2018-03-15 |
20180071245 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2018-03-15 |
20180071246 | ENKEPHALIN-INFLUENCING COMPOSITION AND METHOD | 2018-03-15 |
20180071247 | COMBINATION OF A PD-1 ANTAGONIST AND ERIBULIN FOR TREATING CANCER | 2018-03-15 |
20180071248 | COMPOSITION FOR IMPROVING CIRCADIAN RHYTHM | 2018-03-15 |
20180071249 | COMBINATIONS OF AMISULPRIDE AND ANOTHER ANTI-EMETIC FOR TREATING NAUSEA AND VOMITING | 2018-03-15 |
20180071250 | TESOFENSINE, BETA BLOCKER COMBINATION FORMULATION | 2018-03-15 |
20180071251 | COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER | 2018-03-15 |
20180071252 | METHODS OF TREATING AUTOIMMUNE AND/OR GLOMERULONEPHRITIS-ASSOCIATED DISEASES USING SHP2 INHIBITORS | 2018-03-15 |
20180071253 | METHODS FOR THE TREATMENT OF BLADDER CANCER | 2018-03-15 |
20180071254 | METHODS OF TREATING DEMENTIA AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2018-03-15 |
20180071255 | GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT PANCREATIC CANCER | 2018-03-15 |
20180071256 | COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF PYREXIA IN HORSES | 2018-03-15 |
20180071257 | DIAZOLE AMIDES | 2018-03-15 |
20180071258 | ANTICANCER COMPOUNDS | 2018-03-15 |
20180071259 | METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | 2018-03-15 |
20180071260 | METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS | 2018-03-15 |
20180071261 | CYCLOCREATINE MICROSUSPENSION | 2018-03-15 |
20180071262 | SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE | 2018-03-15 |
20180071263 | BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS | 2018-03-15 |
20180071264 | MAGNESIUM BIOTINATE COMPOSITIONS AND METHODS OF USE | 2018-03-15 |
20180071265 | Method of Treating or Preventing Pathologic Effects of Acute Increases in Hyperglycemia and/or Acute Increases of Free Fatty Acid Flux | 2018-03-15 |
20180071266 | DETECTING AND TREATING GROWTH HORMONE DEFICIENCY | 2018-03-15 |
20180071267 | AMELIORATION OF NEURAL DEFICITS ASSOCIATED WITH DIABETES | 2018-03-15 |
20180071268 | COMPOSITIONS AND METHODS FOR TREATING MICROBIOTA-RELATED PSYCHOTROPIC CONDITIONS AND DISEASES | 2018-03-15 |
20180071269 | THERAPEUTICAL METHODS, FORMULATIONS AND NUTRACEUTICAL FORMULATIONS | 2018-03-15 |
20180071270 | TABLETED COMPOSITIONS CONTAINING ATAZANAVIR | 2018-03-15 |
20180071271 | Fumarate Analogs and Uses Thereof | 2018-03-15 |
20180071272 | NOVEL CHRONOTHERAPY BASED ON CIRCADIAN RHYTHMS | 2018-03-15 |
20180071273 | NUTRITIONAL COMPOSITIONS TO ENHANCE MITOCHONDRIAL ENERGY PRODUCTION | 2018-03-15 |
20180071274 | MEDICAL PRODUCT FOR REDUCING AND/OR ELIMINATING SYMPTOMS OF NICOTINE WITHDRAWAL | 2018-03-15 |
20180071275 | TREATMENT OF OCULAR INFLAMMATORY DISEASES USING LAQUINIMOD | 2018-03-15 |
20180071276 | Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists | 2018-03-15 |
20180071277 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | 2018-03-15 |
20180071279 | METHODS AND COMPOSITIONS FOR TREATING DEGENERATIVE AND ISCHEMIC DISORDERS | 2018-03-15 |
20180071280 | MODULATORS OF CELL DEATH PROCESSES | 2018-03-15 |
20180071281 | TREATING CHRONIC RHINOSINUSITIS | 2018-03-15 |
20180071283 | Treatment of Vasomotor Symptoms | 2018-03-15 |
20180071284 | PREVENTING OR TREATING VIRAL INFECTION BY INHIBITION OF THE HISTONE METHYLTRANSFERASE EZH1 OR EZH2 | 2018-03-15 |
20180071285 | SYSTEMS PHARMACOLOGY FOR TREATING OCULAR DISORDERS | 2018-03-15 |
20180071286 | HETEROARYL PYRIDONE AND AZA-PYRODINE COMPOUNDS | 2018-03-15 |
20180071287 | PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-- 3,4-DIHYDROPYRAZINO [2,3-B]PYRAZIN-2(1H)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE | 2018-03-15 |
20180071288 | FUNCTIONAL CURE OF RETROVIRAL INFECTION | 2018-03-15 |
20180071289 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND RELATED HYPERPROLIFERATIVE DISORDERS | 2018-03-15 |
20180071290 | Solid Pharmaceutical Formulation of PARP Inhibitors and Use Thereof | 2018-03-15 |
20180071291 | Treatment of Respiratory Diseases | 2018-03-15 |
20180071292 | RIBOCICLIB TABLET | 2018-03-15 |
20180071293 | TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY | 2018-03-15 |
20180071294 | METHODS FOR THE TREATMENT OF HER2 AMPLIFIED CANCER | 2018-03-15 |
20180071295 | BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND USES THEREOF | 2018-03-15 |
20180071296 | COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK, AND PIM | 2018-03-15 |
20180071297 | TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-ALPHA SYNTHESIS AND AS PDE4 INHIBITORS | 2018-03-15 |
20180071298 | METHODS FOR TREATING ALZHEIMER'S DISEASE | 2018-03-15 |
20180071299 | METHODS FOR TREATING PSYCHOSIS ASSOCIATED WITH PARKINSON'S DISEASE | 2018-03-15 |
20180071300 | METHOD OF TREATING CANCER | 2018-03-15 |
20180071301 | USE OF NON-PEPTIDE NK1 ANTAGONISTS IN A PREDETERMINED DOSE FOR THE TREATMENT OF CANCER | 2018-03-15 |
20180071302 | SYK INHIBITORS | 2018-03-15 |
20180071303 | SYK INHIBITORS | 2018-03-15 |
20180071304 | Phenoxy Acetic Acids and Phenyl Propionic Acids as PPAR Delta Agonists | 2018-03-15 |
20180071305 | ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG | 2018-03-15 |
20180071306 | CARBAZOLE-CONTAINING SULFONAMIDES AS CRYPTOCHROME MODULATORS | 2018-03-15 |
20180071307 | MEDICINAL COMPOSITION FOR ALLEVIATING ENDOMETRIOSIS AND COMPLICATIONS THEREOF AND USE OF THE SAME | 2018-03-15 |
20180071308 | METHODS FOR FAT REDUCTION | 2018-03-15 |
20180071309 | FULVESTRANT COMPOSITIONS AND METHOD OF USE | 2018-03-15 |
20180071310 | COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS | 2018-03-15 |
20180071311 | PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME | 2018-03-15 |
20180071312 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | 2018-03-15 |
20180071313 | DRY EYE THERAPEUTIC AGENT COMPRISING NANDROLONE OR ESTER THEREOF OR METHENOLONE OR ESTER THEREOF AS AN ACTIVE INGREDIENT | 2018-03-15 |
20180071314 | DEHYDROANDROSTEROL AND METHODS OF USING THE SAME | 2018-03-15 |
20180071315 | Methods of Treating Certain Depressive Disorders and Delirium Tremens | 2018-03-15 |
20180071316 | Compositions And Methods For Treating Dementia | 2018-03-15 |
20180071317 | USE OF AGENTS THAT ALTER THE PERITUMORAL ENVIRONMENT FOR THE TREATMENT OF CANCER | 2018-03-15 |
20180071318 | VITAMIN D RECEPTOR/SMAD GENOMIC CIRCUIT GATES FIBROTIC RESPONSE | 2018-03-15 |
20180071319 | Compositions and Methods for Preventing and Treating Heterotopic Ossification and Pathologic Calcification | 2018-03-15 |
20180071320 | METHODS AND MATERIALS FOR TREATING CALCIFIC AORTIC VALVE STENOSIS | 2018-03-15 |
20180071321 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2018-03-15 |
20180071322 | Neridronic Acid for Treating Complex Regional Pain Syndrome | 2018-03-15 |
20180071323 | ACYCLIC NUCLEOSIDE PHOSPHONATE DIESTERS | 2018-03-15 |
20180071324 | PREPARATION METHOD FOR ANTITUMOR DRUG AP26113 | 2018-03-15 |
20180071325 | CYCLIC BORONIC ACID ESTER DERIVATIVES AND METHODS OF MAKING THE SAME | 2018-03-15 |
20180071326 | METHODS TO PREVENT TISSUE COLONIZATION OF PATHOGENS AND FOR TREATMENT OF BIOFILM ON ANIMAL TISSUES, INCLUDING TREATMENT OF INFECTION | 2018-03-15 |
20180071327 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GLEEVEC-RESISTANT LEUKEMIA CONTAINING GINSENOSIDE F1 OR GINSENOSIDE RG3 AS AN ACTIVE INGREDIENT | 2018-03-15 |